Cme (CME) Receivables (2009 - 2026)

Cme (CME) has reported Receivables for 18 consecutive years, with $753.1 million the latest figure, recorded in Q2 2026.

• Quarterly Receivables rose 12.81% year-over-year to $753.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $753.1 million (up 12.81% YoY) and the FY2025 annual result came in at $639.2 million, up 11.53% from the prior year.
• Receivables fell to $753.1 million in Q2 2026 per CME's latest filing, from $935.5 million in the prior quarter.
• Over the last five years, Receivables for CME reached as high as $935.5 million in Q1 2026 and fell as low as $483.2 million in Q4 2022.
• A 5-year average of $639.5 million and a median of $618.6 million in 2022 frame the typical range for Receivables.
• Annual changes were most pronounced in 2022 — Receivables grew 23.34% — and 2024, when it slipped 13.18%.
• Year by year, Receivables stood at $483.2 million in 2022, then increased by 10.84% to $535.6 million in 2023, then grew by 7.0% to $573.1 million in 2024, then increased by 11.53% to $639.2 million in 2025, then gained by 17.82% to $753.1 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $753.1 million, $935.5 million, and $639.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.